Breast MRI: EUSOBI recommendations for women's information
Mann RM (1), Balleyguier C (2), Baltzer PA (3), Bick U (4), Colin C (5), Cornford E (6), Evans A (7), Fallenberg E (4), Forrai G (8), Fuchsjäger MH (9), Gilbert FJ (10), Helbich TH (3), Heywang-Köbrunner SH (11), Camps-Herrero J (12), Kuhl CK (13), Martincich L (14), Pediconi F (15), Panizza P (16), Pina LJ (17), Pijnappel RM (18), Pinker-Domenig K (3), Skaane P (19), Sardanelli F (20); European Society of Breast Imaging (EUSOBI), with language review by Europa Donna–The European Breast Cancer Coalition.
This paper summarizes information about breast MRI to be provided to women and referring physicians. After listing contraindications, procedure details are described, stressing the need for correct scheduling and not moving during the examination.
The structured report including BI-RADS® categories and further actions after a breast MRI examination are discussed. Breast MRI is a very sensitive modality, significantly improving screening in high-risk women. It also has a role in clinical diagnosis, problem solving, and staging, impacting on patient management. However, it is not a perfect test, and occasionally breast cancers can be missed.
Therefore, clinical and other imaging findings (from mammography/ultrasound) should also be considered. Conversely, MRI may detect lesions not visible on other imaging modalities turning out to be benign (false positives).
These risks should be discussed with women before a breast MRI is requested/performed. Because breast MRI drawbacks depend upon the indication for the examination, basic information for the most important breast MRI indications is presented. Seventeen notes and five frequently asked questions formulated for use as direct communication to women are provided. The text was reviewed by Europa Donna-The European Breast Cancer Coalition to ensure that it can be easily understood by women undergoing MRI.